Le Lézard
Classified in: Health, Science and technology
Subject: PLW

DECISIO® Gains Key Patent for Unique Clinical Dashboard


HOUSTON, May 9, 2022 /PRNewswire/ -- DECISIO announced yesterday the issuance of US Patent 11,309,079 B2, which related to a system, method, and computer program product for providing a patient dashboard system in a hospital setting.  The patent covers a method of displaying information in a patient care setting using a real-time monitoring dashboard. It further covers the collection and aggregation of clinical information from multiple sources to interpret and display actionable insights, to the right person, at the right time, every time.

Patent 11,309,079 B2, titled, 'System And Method For A Patient Dashboard', filters, analyzes, and displays patient data that is relevant to the treatment of the patient, including recommended medical actions and pertinent positive and negative results.

The company recently rebranded DECISIO and launched a new website. The flagship product, previously DECISIOInsight, is now named InsightIQtm. InsightIQ reduces clinical variation with digitized bundles of care that prioritizes clinicians' attention to at-risk, deteriorating patients for early intervention.  EnvisionIQtm, a clinical analytics platform, was announced in early 2022 and paves the way for a whole suite of DECISIO IQ products to be announced in the near future. 

"The changes we have made at DECISIO over the course of the past several months only strengthens the confidence we have in the huge potential to innovate and improve this space within the healthcare market," said Co-CEO Dr. John Holcomb. "We have many opportunities in front of us and I am certain that we are on the road to success." 

About DECISIO® DECISIO is a Houston-based digital health company with a customizable clinical decision support platform designed to aggregate and prioritize real-time data, from any device, and present it visually in one place. The flagship product, InsightIQ, uses continuous smart bedside monitoring which enables clinical teams to efficiently identify patients at risk and comply with established clinical guidelines.  InsightIQ improves patient outcomes and throughput, optimizes workflow, increases collaboration, thus reducing length of stay and "click" fatigue.  Our solutions, including actionable analytics, can be scaled across an entire health system or used in a single care area.  For more information, visit www.decisiohealth.com.

Contact Information
Paul Sinclair
DECISIO 
[email protected] 

SOURCE Decisio Health


These press releases may also interest you

at 20:50
MiniTool Software Limited has released a new version of its video making program ? MiniTool MovieMaker 7.3.0 with brand-new resources to decorate videos effortlessly....

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 20:00
OKX Ventures, the investment arm of leading crypto exchange and Web3 technology company OKX, today announced its participation in the 'Runes Incubator.' This program, initiated by OnePiece Labs and supported by Merlin Chain and Franklin Templeton,...

at 20:00
SK hynix Inc. (or "the company", www.skhynix.com) announced today that it has recently signed a memorandum of understanding with TSMC for collaboration to...

at 19:27
ShipSaving, a fast-growing shipping platform recognized in the 2023 Deloitte Technology Fast 500tm, proudly announces a groundbreaking development as the first multi-carrier shipping company to offer UPS no-label shipping. This innovative feature...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: